Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Niraparib
Niraparib
1038915-60-4
|
320.164
|
2.722
Niraparib is an orally active PARP inhibitor. It is used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy.
((S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide) | 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide | 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide | 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide | MK-4827 | Zejula | niraparib
Niraparib is an orally active PARP inhibitor. It is used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy.
((S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide) | 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide | 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide | 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide | MK-4827 | Zejula | niraparib
$41/5 mg
(EBC)
1
We provide 0 compound for Niraparib